Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
Sec Filings Insider Trading - Intellia Therapeutics Inc. (NTLA)
Select Time period:       google icon google     yahoo icon yahoo!
Send this page to:   blogger icon Blog    digg icon Digg    reddit icon Reddit    facebook icon Facebook    stumble icon Stumble    delicious icon del.icio.us

Enter Stock Ticker Symbol or Cik: SEC Cik Lookup Cik Lookup...

Search By Company or Insider Name: Powered by Google button
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch ==>> What is insider trading>>
NTLA Insider Trading Transactions for Intellia Therapeutics Inc.
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In

Common stock purchase or sale:
Transaction
Date
Reported
Date
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-07-07
Sale
2017-07-11
5:40 pm
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
150,000 $16.24 $2,435,440 3,699,788
(Indirect)
View
2017-07-07
Sale
2017-07-11
5:37 pm
Intellia Therapeutics Inc. NTLA Atlas Venture Fund Ix L.P.
Atlas Venture Associates Ix L.P.
Atlas Venture Associates Ix LLC
10% Owner
150,000 $16.24 $2,435,440 3,699,788
(Direct)
View
2017-03-09
Sale
2017-03-13
10:39 am
Intellia Therapeutics Inc. NTLA Atlas Venture Associates Ix L.P.
Atlas Venture Associates Ix LLC
10% Owner
21,132 $13.91 $293,843 3,729,788
(Indirect
Direct)
View
2017-03-09
Sale
2017-03-13
10:34 am
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
21,132 $13.91 $293,843 3,729,788
(Indirect)
View
2016-05-11
Purchase
2016-05-13
4:58 pm
Intellia Therapeutics Inc. NTLA Orbimed Advisors LLC
Orbimed Capital Gp V LLC
Orbimed Global Healthcare Gp LLC
Isaly Samuel D
Director
250,000 $18 $4,500,000 2,662,180
(Indirect)
View
2016-05-11
Purchase
2016-05-13
06:15 am
Intellia Therapeutics Inc. NTLA Temasek Holdings (private) Ltd
Fullerton Management Pte Ltd
Temasek Life Sciences Private Ltd
Tls Beta Pte. Ltd.
10% Owner
300,000 $18 $5,400,000 790,527
(Indirect)
View
2016-05-11
Purchase
2016-05-11
6:57 pm
Intellia Therapeutics Inc. NTLA Novartis Institutes For Biomedical Research Inc.
Novartis Ag
10% Owner
277,777 $18 $4,999,986 5,573,658
(Direct)
View
2016-05-11
Purchase
2016-05-11
6:36 pm
Intellia Therapeutics Inc. NTLA Gordon Carl L
Director
250,000 $18 $4,500,000 2,662,180
(Indirect)
View
2016-05-11
Purchase
2016-05-11
4:25 pm
Intellia Therapeutics Inc. NTLA Baker BROS. Advisors Lp
Baker Felix
Baker Julian
Baker Bros. Advisors (gp) LLC
Other
200,000 $18 $3,600,000 976,214
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
Date
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-07-25
Option Award
2017-07-25
4:49 pm
N/A
2027-07-24
Intellia Therapeutics Inc. NTLA Verwiel Frank
Director
38,000 $16.91 38,000
(Direct)
View
2017-07-25
Option Award
2017-07-25
4:47 pm
N/A
2027-07-24
Intellia Therapeutics Inc. NTLA Slaoui Moncef
Director
38,000 $16.91 38,000
(Direct)
View
2016-06-02
Option Award
2017-06-05
08:03 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Dorsa Caroline
Director
5,000 $12.42 5,000
(Direct)
View
2017-06-01
Option Award
2017-06-05
08:01 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Karsen Perry A
Director
5,000 $11.98 5,000
(Direct)
View
2017-06-02
Option Award
2017-06-05
07:59 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Bell Graeme
EVP, Chief Financial Officer
8,400 $12.37 8,400
(Direct)
View
2017-06-01
Option Award
2017-06-05
07:57 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Rivera Jose E
EVP, General Counsel & Ops
8,400 $12.03 262,210
(Direct)
View
2017-06-01
Option Award
2017-06-05
07:55 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Leonard John M.
EVP, R&D
Director
7,800 $12.06 466,408
(Indirect)
View
2017-06-01
Option Award
2017-06-05
07:55 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Leonard John M.
EVP, R&D
Director
600 $12.09 466,408
(Indirect)
View
2017-06-01
Option Award
2017-06-05
07:53 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Bermingham Nessan
President & CEO
Director
8,400 $11.95 795,033
(Direct)
View
2017-05-18
Option Award
2017-05-19
5:14 pm
N/A
2027-05-17
Intellia Therapeutics Inc. NTLA Dorsa Caroline
Director
19,000 $14.35 19,000
(Direct)
View
2017-05-18
Option Award
2017-05-19
5:12 pm
N/A
2027-05-17
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
19,000 $14.35 19,000
(Direct)
View
2017-05-18
Option Award
2017-05-19
5:10 pm
N/A
2027-05-17
Intellia Therapeutics Inc. NTLA Gordon Carl L
Director
19,000 $14.35 19,000
(Direct)
View
2017-05-18
Option Award
2017-05-19
5:08 pm
N/A
2027-05-17
Intellia Therapeutics Inc. NTLA Karsen Perry A
Director
19,000 $14.35 19,000
(Direct)
View
2017-03-03
Other
2017-03-07
3:11 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Novartis Institutes For Biomedical Research Inc.
Novartis Ag
10% Owner
79,245 $0 5,652,903
(Direct)
View
2017-03-03
Other
2017-03-07
08:35 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Atlas Venture Fund Ix L.P.
Atlas Venture Associates Ix L.P.
Atlas Venture Associates Ix LLC
10% Owner
700,000 $0 3,729,788
(Direct)
View
2017-01-06
Option Award
2017-01-10
8:12 pm
N/A
2027-01-05
Intellia Therapeutics Inc. NTLA Heifner Nicole
SVP, Accounting
28,500 $13.88 28,500
(Direct)
View
2017-01-06
Option Award
2017-01-10
8:11 pm
N/A
2027-01-05
Intellia Therapeutics Inc. NTLA Morrissey David V
SVP, Platform & Delivery Tech
30,000 $13.88 30,000
(Direct)
View
2017-01-06
Option Award
2017-01-10
8:09 pm
N/A
2027-01-05
Intellia Therapeutics Inc. NTLA Barnes Thomas M.
SVP, R&D eXtellia
50,500 $13.88 50,500
(Direct)
View
2017-01-06
Option Award
2017-01-10
8:07 pm
N/A
2027-01-05
Intellia Therapeutics Inc. NTLA Leonard John M.
EVP, R&D
Director
95,000 $13.88 95,000
(Direct)
View
2017-01-06
Option Award
2017-01-10
8:05 pm
N/A
2027-01-05
Intellia Therapeutics Inc. NTLA Rivera Jose E
EVP, General Counsel & Ops
115,000 $13.88 115,000
(Direct)
View
2017-01-06
Option Award
2017-01-10
8:03 pm
N/A
2027-01-05
Intellia Therapeutics Inc. NTLA Bermingham Nessan
President & CEO
Director
270,000 $13.88 270,000
(Direct)
View
2017-01-03
Option Award
2017-01-05
5:57 pm
N/A
2027-01-02
Intellia Therapeutics Inc. NTLA Bell Graeme
EVP, Chief Financial Officer
210,000 $13.48 210,000
(Direct)
View
2016-05-11
Conversion
2016-05-13
4:58 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Orbimed Advisors LLC
Orbimed Capital Gp V LLC
Orbimed Global Healthcare Gp LLC
Isaly Samuel D
Director
1,847,400 $0 2,662,180
(Indirect)
View
2016-05-11
Conversion
2016-05-13
4:58 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Orbimed Advisors LLC
Orbimed Capital Gp V LLC
Orbimed Global Healthcare Gp LLC
Isaly Samuel D
Director
564,780 $0 2,662,180
(Indirect)
View
2016-05-11
Conversion
2016-05-13
4:58 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Orbimed Advisors LLC
Orbimed Capital Gp V LLC
Orbimed Global Healthcare Gp LLC
Isaly Samuel D
Director
2,857,143 $0 2,662,180
(Indirect)
View
2016-05-11
Conversion
2016-05-13
4:58 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Orbimed Advisors LLC
Orbimed Capital Gp V LLC
Orbimed Global Healthcare Gp LLC
Isaly Samuel D
Director
873,475 $0 2,662,180
(Indirect)
View
2016-05-11
Conversion
2016-05-13
06:15 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Temasek Holdings (private) Ltd
Fullerton Management Pte Ltd
Temasek Life Sciences Private Ltd
Tls Beta Pte. Ltd.
10% Owner
490,527 $0 790,527
(Indirect)
View
2016-05-11
Conversion
2016-05-13
06:15 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Temasek Holdings (private) Ltd
Fullerton Management Pte Ltd
Temasek Life Sciences Private Ltd
Tls Beta Pte. Ltd.
10% Owner
490,527 $0 790,527
(Indirect)
View
2016-05-11
Conversion
2016-05-11
7:01 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
611,827 $0 4,429,788
(Indirect)
View
2016-05-11
Conversion
2016-05-11
7:01 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
2,463,201 $0 4,429,788
(Indirect)
View
2016-05-11
Conversion
2016-05-11
7:01 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
862,120 $0 4,429,788
(Indirect)
View
2016-05-11
Conversion
2016-05-11
7:01 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
492,640 $0 4,429,788
(Indirect)
View
2016-05-11
Conversion
2016-05-11
7:01 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
946,237 $0 4,429,788
(Indirect)
View
2016-05-11
Conversion
2016-05-11
7:01 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
3,809,524 $0 4,429,788
(Indirect)
View
2016-05-11
Conversion
2016-05-11
7:01 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
1,333,333 $0 4,429,788
(Indirect)
View
2016-05-11
Conversion
2016-05-11
7:01 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
761,905 $0 4,429,788
(Indirect)
View
2016-05-11
Conversion
2016-05-11
6:59 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Atlas Venture Fund Ix L.P.
Atlas Venture Associates Ix L.P.
Atlas Venture Associates Ix LLC
10% Owner
611,827 $0 4,429,788
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:59 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Atlas Venture Fund Ix L.P.
Atlas Venture Associates Ix L.P.
Atlas Venture Associates Ix LLC
10% Owner
2,463,201 $0 4,429,788
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:59 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Atlas Venture Fund Ix L.P.
Atlas Venture Associates Ix L.P.
Atlas Venture Associates Ix LLC
10% Owner
862,120 $0 4,429,788
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:59 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Atlas Venture Fund Ix L.P.
Atlas Venture Associates Ix L.P.
Atlas Venture Associates Ix LLC
10% Owner
492,640 $0 4,429,788
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:59 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Atlas Venture Fund Ix L.P.
Atlas Venture Associates Ix L.P.
Atlas Venture Associates Ix LLC
10% Owner
946,237 $0 4,429,788
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:59 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Atlas Venture Fund Ix L.P.
Atlas Venture Associates Ix L.P.
Atlas Venture Associates Ix LLC
10% Owner
3,809,524 $0 4,429,788
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:59 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Atlas Venture Fund Ix L.P.
Atlas Venture Associates Ix L.P.
Atlas Venture Associates Ix LLC
10% Owner
1,333,333 $0 4,429,788
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:59 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Atlas Venture Fund Ix L.P.
Atlas Venture Associates Ix L.P.
Atlas Venture Associates Ix LLC
10% Owner
761,905 $0 4,429,788
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:57 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Novartis Institutes For Biomedical Research Inc.
Novartis Ag
10% Owner
3,079,001 $0 5,573,658
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:57 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Novartis Institutes For Biomedical Research Inc.
Novartis Ag
10% Owner
1,724,240 $0 5,573,658
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:57 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Novartis Institutes For Biomedical Research Inc.
Novartis Ag
10% Owner
492,640 $0 5,573,658
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:57 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Novartis Institutes For Biomedical Research Inc.
Novartis Ag
10% Owner
4,761,905 $0 5,573,658
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:57 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Novartis Institutes For Biomedical Research Inc.
Novartis Ag
10% Owner
2,666,666 $0 5,573,658
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:57 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Novartis Institutes For Biomedical Research Inc.
Novartis Ag
10% Owner
761,905 $0 5,573,658
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:40 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Haurwitz Rachel E.
Director
10% Owner
174,806 $0 5,593,846
(Indirect)
View
2016-05-11
Conversion
2016-05-11
6:40 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Haurwitz Rachel E.
Director
10% Owner
5,244,234 $0 5,593,846
(Indirect)
View
2016-05-11
Conversion
2016-05-11
6:40 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Haurwitz Rachel E.
Director
10% Owner
270,352 $0 5,593,846
(Indirect)
View
2016-05-11
Conversion
2016-05-11
6:40 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Haurwitz Rachel E.
Director
10% Owner
8,110,599 $0 5,593,846
(Indirect)
View
2016-05-11
Conversion
2016-05-11
6:38 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Caribou Therapeutics Holdco LLC
Caribou Biosciences Inc.
10% Owner
174,806 $0 5,593,846
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:38 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Caribou Therapeutics Holdco LLC
Caribou Biosciences Inc.
10% Owner
5,244,234 $0 5,593,846
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:38 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Caribou Therapeutics Holdco LLC
Caribou Biosciences Inc.
10% Owner
270,352 $0 5,593,846
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:38 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Caribou Therapeutics Holdco LLC
Caribou Biosciences Inc.
10% Owner
8,110,599 $0 5,593,846
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:36 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Gordon Carl L
Director
1,847,400 $0 2,662,180
(Indirect)
View
2016-05-11
Conversion
2016-05-11
6:36 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Gordon Carl L
Director
564,780 $0 2,662,180
(Indirect)
View
2016-05-11
Conversion
2016-05-11
6:36 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Gordon Carl L
Director
2,857,143 $0 2,662,180
(Indirect)
View
2016-05-11
Conversion
2016-05-11
6:36 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Gordon Carl L
Director
873,475 $0 2,662,180
(Indirect)
View
2016-05-11
Conversion
2016-05-11
6:33 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Bermingham Nessan
President & CEO
Director
437,019 $0 786,633
(Direct)
View
2016-05-11
Conversion
2016-05-11
6:33 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Bermingham Nessan
President & CEO
Director
675,883 $0 786,633
(Direct)
View
2016-05-11
Conversion
2016-05-11
4:25 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Baker BROS. Advisors Lp
Baker Felix
Baker Julian
Baker Bros. Advisors (gp) LLC
Other
65,437 $0 976,214
(Indirect)
View
2016-05-11
Conversion
2016-05-11
4:25 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Baker BROS. Advisors Lp
Baker Felix
Baker Julian
Baker Bros. Advisors (gp) LLC
Other
796,683 $0 976,214
(Indirect)
View
2016-05-11
Conversion
2016-05-11
4:25 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Baker BROS. Advisors Lp
Baker Felix
Baker Julian
Baker Bros. Advisors (gp) LLC
Other
101,204 $0 976,214
(Indirect)
View
2016-05-11
Conversion
2016-05-11
4:25 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Baker BROS. Advisors Lp
Baker Felix
Baker Julian
Baker Bros. Advisors (gp) LLC
Other
1,232,130 $0 976,214
(Indirect)
View
2016-05-05
Option Award
2016-05-09
5:49 pm
N/A
2026-05-04
Intellia Therapeutics Inc. NTLA Formela Jean Francois
Director
23,529 $18 23,529
(Direct)
View
2016-05-05
Option Award
2016-05-09
5:47 pm
N/A
2026-05-04
Intellia Therapeutics Inc. NTLA Gordon Carl L
Director
10% Owner
23,529 $18 23,529
(Direct)
View
2016-05-05
Option Award
2016-05-09
5:44 pm
N/A
2026-05-04
Intellia Therapeutics Inc. NTLA Haurwitz Rachel E.
Director
10% Owner
23,529 $18 23,529
(Direct)
View
2016-05-05
Option Award
2016-05-09
5:43 pm
N/A
2026-05-04
Intellia Therapeutics Inc. NTLA Karsen Perry A
Director
31,764 $18 31,764
(Direct)
View
2016-05-05
Option Award
2016-05-09
5:41 pm
N/A
2026-05-04
Intellia Therapeutics Inc. NTLA Dorsa Caroline
Director
15,176 $18 15,176
(Direct)
View